Yoffe Investment Management LLC Acquires New Position in Haleon plc (NYSE:HLN)

Yoffe Investment Management LLC bought a new position in Haleon plc (NYSE:HLN) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 17,073 shares of the company’s stock, valued at approximately $163,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of HLN. Pitcairn Co. grew its position in shares of Haleon by 10.3% during the fourth quarter. Pitcairn Co. now owns 275,848 shares of the company’s stock worth $2,632,000 after acquiring an additional 25,661 shares during the last quarter. National Bank of Canada FI grew its position in Haleon by 195.8% in the 4th quarter. National Bank of Canada FI now owns 13,992 shares of the company’s stock worth $133,000 after purchasing an additional 9,262 shares during the last quarter. HighPoint Advisor Group LLC grew its position in Haleon by 6.2% in the 4th quarter. HighPoint Advisor Group LLC now owns 37,768 shares of the company’s stock worth $372,000 after purchasing an additional 2,213 shares during the last quarter. Alliancebernstein L.P. increased its stake in shares of Haleon by 28.1% in the fourth quarter. Alliancebernstein L.P. now owns 51,678 shares of the company’s stock valued at $493,000 after purchasing an additional 11,341 shares during the period. Finally, Wellington Management Group LLP raised its holdings in shares of Haleon by 67.5% during the fourth quarter. Wellington Management Group LLP now owns 15,328,325 shares of the company’s stock valued at $146,232,000 after buying an additional 6,175,835 shares during the last quarter. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms recently commented on HLN. Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Hsbc Global Res lowered Haleon from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Haleon in a report on Monday, March 3rd. Morgan Stanley cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Finally, HSBC reaffirmed a “hold” rating on shares of Haleon in a research note on Wednesday, March 5th. Six research analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Haleon has a consensus rating of “Hold” and a consensus price target of $10.95.

Haleon Trading Down 5.4 %

Shares of HLN stock opened at $9.89 on Friday. The stock has a 50-day simple moving average of $10.03 and a 200 day simple moving average of $9.87. The stock has a market capitalization of $44.75 billion, a P/E ratio of 29.07, a P/E/G ratio of 2.82 and a beta of 0.25. Haleon plc has a fifty-two week low of $7.99 and a fifty-two week high of $10.80. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44.

Haleon (NYSE:HLN) last issued its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The company had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. On average, sell-side analysts expect that Haleon plc will post 0.43 earnings per share for the current fiscal year.

Haleon Increases Dividend

The business also recently declared a — dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be issued a $0.1166 dividend. The ex-dividend date is Friday, April 25th. This represents a dividend yield of 1.6%. This is a boost from Haleon’s previous — dividend of $0.05. Haleon’s dividend payout ratio is currently 58.97%.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.